Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

31-year-old man survives cardiac arrest without neurological sequelae

In Europe, around 500,000 people suffer a sudden cardiac arrest every year. Outside of a hospital, only about 8% of those affected survive, and a high percentage of survivors suffer from neurological sequelae after resuscitation.

A high percentage of survivors suffer from neurological sequelae after resuscitation. To improve this, CARL, as extracorporeal resuscitation, is an additional therapeutic option when interventions such as chest compressions or AEDs fail to reestablish spontaneous circulation. Here, the rescue team performs a controlled reperfusion adapted to the individual patient to maximize the potential for resuscitation.

Max Parpart

Max experienced a completely normal morning, except for one thing: He felt a slight pressure on his chest. When he also started having breathing problems, he immediately made an appointment with his family doctor. But he was unable to keep it, because shortly thereafter Max suddenly collapsed in his own apartment. In retrospect, it turned out that he had suffered a severe heart attack at that moment. His girlfriend, who was fortunately with him, immediately alerted the rescue service. The quick help and close proximity to the Medical Center – University of Freiburg were a great stroke of luck for Max: After 50 minutes of resuscitation, he was connected to the CARL System while still in his apartment. He was in coma for six long weeks, then he woke up and it turned out that the CARL Therapy not only saved his life. In fact, despite his severe illness, the then 31-year-old has shown no motor or neurological limitations to date. Max regained his life and can even work again in his profession as a cook. One thing that has changed for him, however, is his focus on the essentials: Spending time with his family is now his top priority.


Resuscitec GmbH
Engesserstraße 4a
D-79108 Freiburg


Sie erhalten das Presseclipping der Resuscitec GmbH aufgrund Ihrer Beziehung zu unserem Unternehmen. Wir verarbeiten Ihre Daten auf Grundlage unseres berechtigten Interesses zum Zweck der persönlichen Ansprache und zum Versand unseres Presseclippings. Verantwortlich für die Datenverarbeitung ist die Resuscitec GmbH. Weitere Informationen zum Datenschutz finden Sie in unseren Datenschutzhinweisen. Sie können der Verarbeitung Ihrer personenbezogenen Daten für den Versand des Presseclippings jederzeit formlos widersprechen.


Aus urheberrechtlichen Gründen dürfen die Artikel weder in digitaler noch ausgedruckter Form an Dritte weitergegeben werden. Sie sind nur zum persönlichen Gebrauch bestimmt, der Aufbau einer Datenbank mit digitalisierten Artikeln ist nicht erlaubt.